Sera Prognostics (SERA) Long-Term Investments (2021 - 2026)
Sera Prognostics' (SERA) quarterly Long-Term Investments came in at $39.4 million in Q1 2026, down 42.11% YoY from $68.0 million in Q1 2025, and down 30.42% on a QoQ basis from $56.6 million in Q4 2025.
Sera Prognostics (SERA) Long-Term Investments (2021 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 6 years of Long-Term Investments data on file, last reported at $39.4 million in Q1 2026.
- Quarterly Long-Term Investments fell 42.11% year-over-year to $39.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.4 million (down 42.11% YoY) and the FY2025 annual result came in at $56.6 million, up 157.49% from the prior year.
- Long-Term Investments slipped to $39.4 million in Q1 2026, from $56.6 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $68.4 million in Q2 2025 to a low of $13.7 million in Q2 2022.
- A 5-year average of $35.7 million and a median of $30.0 million in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2025 — Long-Term Investments surged 157.49% — and 2026, when it tumbled 42.11%.
- Tracing SERA's Long-Term Investments over 5 years: stood at $21.3 million in 2022, then soared by 44.6% to $30.8 million in 2023, then dropped by 28.75% to $22.0 million in 2024, then jumped by 157.49% to $56.6 million in 2025, then sank by 30.42% to $39.4 million in 2026.
- The last three Long-Term Investments figures came in at $39.4 million (Q1 2026), $56.6 million (Q4 2025), and $59.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | 33.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.81 Mn |
| Mar 31, 2026 | 39.37 Mn |
| Dec 31, 2025 | 56.58 Mn |
| Sep 30, 2025 | 59.08 Mn |
| Jun 30, 2025 | 68.35 Mn |
| Mar 31, 2025 | 68.00 Mn |
| Dec 31, 2024 | 21.97 Mn |
| Sep 30, 2024 | 24.59 Mn |
| Jun 30, 2024 | 30.01 Mn |
| Mar 31, 2024 | 32.39 Mn |
| Dec 31, 2023 | 30.84 Mn |
| Sep 30, 2023 | 38.92 Mn |
| Jun 30, 2023 | 28.31 Mn |
| Mar 31, 2023 | 28.92 Mn |
| Dec 31, 2022 | 21.33 Mn |
| Sep 30, 2022 | 22.38 Mn |
| Jun 30, 2022 | 13.68 Mn |
| Mar 31, 2022 | 22.34 Mn |
| Dec 31, 2021 | 34.85 Mn |
| Sep 30, 2021 | 30.00 Mn |